Mirae Asset Global ETFs Holdings’s Arbutus Biopharma ABUS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$356K	Buy	79,466 +2,307	+3%	+$10.1K	﹤0.01%	2063
2025 Q4	$370K	Buy	77,159 +3,353	+5%	+$15.1K	﹤0.01%	2039
2025 Q3	$335K	Sell	73,806 -13,543	-16%	-$49.7K	﹤0.01%	2055
2025 Q2	$270K	Sell	87,349 -3,820	-4%	-$12.7K	﹤0.01%	2122
2025 Q1	$318K	Buy	91,169 +1,772	+2%	+$5.91K	﹤0.01%	2085
2024 Q4	$292K	Buy	89,397 +8,308	+10%	+$30.6K	﹤0.01%	2189
2024 Q3	$312K	Buy	81,089 +16,009	+25%	+$61.4K	﹤0.01%	2145
2024 Q2	$201K	Buy	+65,080	New	+$195K	﹤0.01%	2249

Other funds holding ABUS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

WCM

Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ABUS Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Arbutus Biopharma (ABUS) stake by 3% in Q1 2026, buying an estimated $10.1K and bringing the position to 79,466 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #2063.

Mirae Asset Global ETFs Holdings first reported a position in ABUS in Q2 2024 and has held it in 8 quarters since. The position peaked at $370K in Q4 2025. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.

Mirae Asset Global ETFs Holdings held 79,466 shares of Arbutus Biopharma worth $356K as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 2,307 Arbutus Biopharma shares in Q1 2026, an estimated $10.1K.
Arbutus Biopharma made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2063 holding.
Mirae Asset Global ETFs Holdings first reported a position in Arbutus Biopharma in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Arbutus Biopharma position peaked at $370K in Q4 2025.
167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.